PIK3CA and breast cancer: Taken together, depletion of mevalonate, FPP and GGPP by simvastatin contributes to simvastatin-induced apoptosis, proliferation inhibition and deactivation of PI3K/Akt and MAPK/ERK pathways in breast cancer cell lines.